Condition
Traumatic Shock
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05738642Not ApplicableCompleted
Efficacy and Safety of Early Use PCC in Severe Trauma
NCT06270615Completed
Prospective Validation of the SHOCKMATRIX Hemorrhage Predictive Model
NCT04497155CompletedPrimary
Prehospital Norepinephrine and Early Mortality in Traumatic Shock
NCT01611935Phase 2CompletedPrimary
AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Showing all 4 trials